(Q44023429)

English

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study (English)

1 reference

Europe PubMed Central

29 November 2017

0 references

0 references

alcohol dependence

1 reference

based on heuristic

inferred from title

Ralitza Gueorguieva

object named as

Ralitza Gueorguieva

2

0 references

object named as

Joel Gelernter

1

0 references

Robert A. Rosenheck

6

object named as

Robert Rosenheck

1 reference

Europe PubMed Central

29 November 2017

7

object named as

John H Krystal

1 reference

Europe PubMed Central

29 November 2017

Henry R. Kranzler

3

object named as

Henry R Kranzler

1 reference

Europe PubMed Central

29 November 2017

author name string

Huiping Zhang

4

1 reference

Europe PubMed Central

29 November 2017

Joyce Cramer

5

1 reference

Europe PubMed Central

29 November 2017

VA Cooperative Study #425 Study Group

8

1 reference

Europe PubMed Central

29 November 2017

publication date

1 April 2007

1 reference

Europe PubMed Central

29 November 2017

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

29 November 2017

31

1 reference

Europe PubMed Central

29 November 2017

4

1 reference

Europe PubMed Central

29 November 2017

555-563

1 reference

Europe PubMed Central

29 November 2017

Interrogating a high-density SNP map for signatures of natural selection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Allelic and haplotypic association of GABRA2 with alcohol dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

PowerMarker: an integrated analysis environment for genetic marker analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Physicians’ opinions about medications to treat alcoholism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Predicting treatment response to naltrexone: the influence of craving and family history

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Variant detection at the ? opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2007.00339.X

21 January 2018

Identifiers

10.1111/J.1530-0277.2007.00339.X

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44023429&oldid=2136094956"